PlainPharmaWatch

CMS Open Payments · Tool

Dentsply Sirona Inc vs Exactech, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Exactech, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 722, versus 679 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Dentsply Sirona Inc
HHI 679 · top recipient 0.2%
Ranked #1,180 of 1,838 companies by HHI
Exactech, Inc.
HHI 722 · top recipient 0.2%
Ranked #1,159 of 1,838 companies by HHI

Payment Overview

Total Payments
$10.4M
% of Industry
0.1%
Transactions
68,448
Avg per Transaction
$152.52
Recipients
68,448
Avg per Recipient
$152.52
Payment Types
11
Top Payment Type
Royalty or License
Company B

Exactech, Inc.

Total Payments
$10.4M
% of Industry
0.1%
Transactions
2,386
Avg per Transaction
$4.3K
Recipients
2,226
Avg per Recipient
$4.7K
Payment Types
6
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Dentsply Sirona Inc vs Exactech, Inc. - total reported payments in CMS Open Payments PY2024

Dentsply Sirona Inc$10.4MExactech, Inc.$10.4M

Payment Types Breakdown

Dentsply Sirona Inc

Royalty or License $4.5M

42.7%

Compensation for Services Other Than Consulting $2.9M

27.3%

Food and Beverage $1.6M

15.8%

Travel and Lodging $564.4K

5.4%

Education $308.3K

3.0%

Gift $265.2K

2.5%

Exactech, Inc.

Royalty or License $6.0M

57.5%

Consulting Fee $1.5M

14.4%

Travel and Lodging $364.1K

3.5%

Space Rental or Facility Fees $157.5K

1.5%

Food and Beverage $151.9K

1.5%

Education $160.49

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Dentsply Sirona Inc

  1. 1

    CLIFFORD RUDDLE

    $2,093,678.75 · 60 txns

  2. 2

    MICHAEL SCIANAMBLO

    $1,295,761.17 · 20 txns

  3. 3

    JOHN WEST

    $1,004,233.79 · 22 txns

  4. 4

    DAVID LANDWEHR

    $242,811.43 · 136 txns

  5. 5

    DAVID BARACK

    $181,583.79 · 52 txns

Exactech, Inc.

  1. 1

    JOSEPH ZUCKERMAN

    $1,853,154.71 · 24 txns

  2. 2

    HOSPITAL FOR SPECIAL SURGERY

    $719,838.64 · 6 txns

  3. 3

    THOMAS W. WRIGHT

    $464,577.74 · 26 txns

  4. 4

    THOMAS WARD THROCKMORTON

    $327,667.55 · 10 txns

  5. 5

    STEPHEN F. BROCKMEIER

    $301,875.99 · 22 txns

Summary Comparison

Metric Dentsply Sirona Inc Exactech, Inc.
Total Payments $10.4M $10.4M
% of Industry Total 0.1% 0.1%
Transaction Count 68,448 2,386
Avg per Transaction $152.52 $4.3K
Recipient Count 68,448 2,226
Avg per Recipient $152.52 $4.7K
Payment Type Count 11 6
Top Payment Type Royalty or License Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.